IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+2.7%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$310M
AUM Growth
+$310M
(+3%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-4.2%
Top 10 Holdings %
Top 10 Hldgs %
58.2%
Holding
58
New
5
Increased
12
Reduced
7
Closed
5
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$11.2M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$7.47M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$6.01M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$5.96M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$4.77M |
Top Sells
Sector Composition
| 1 | Healthcare | 98.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Esperion Therapeutics
ESPR
$490M
| $353K | 0.11% |
9,500
| – | – |
|
|
ZEAL
52
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $210K | 0.07% |
5,653
| – | – |
|
53
AnaptysBio
ANAB
$630M
| $148K | 0.05% |
10,000
| – | – |
|
|
ZGNX
54
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
-236,832
| Closed | -$6.17M |
|
|
PRNB
55
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| – | – |
-23,100
| Closed | -$1.3M |
|
|
MNTA
56
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| – | – |
-27,000
| Closed | -$970K |
|
|
SAGE
57
DELISTED
Sage Therapeutics
SAGE
| – | – |
-37,600
| Closed | -$1.57M |
|
58
Enanta Pharmaceuticals
ENTA
$189M
| – | – |
-46,500
| Closed | -$2.28M |
|